Clinical Trials Browser

OTHER × Uveal Melanoma × Chemotherapy, Adjuvant × Clear all

NCT00025181 2014-05-22

Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery

Phase 1 Completed

Uveal Melanoma, Melanoma

NCT00031733 2014-05-22

Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma

Phase 2 Completed

Uveal Melanoma, Melanoma